Questions over recent microplastics studies are putting new pressure on the packaging sector to separate solid science from alarming claims. Over the past few years, research has suggested that plastic particles from bottles, food packaging and waste may be present in human blood, lungs, placentas, arteries and even the brain. However, scrutiny of some studies shows that the science of detecting these particles in human tissue is still developing and far from simple.

The concern is understandable. Plastic packaging is widely used across food, drink, healthcare and consumer goods, and small fragments are now known to be present across the environment. Exposure is therefore difficult to avoid. But detecting microplastics and nanoplastics inside the human body requires extremely sensitive analytical methods, and those methods can be affected by contamination from the very laboratory equipment used to process samples.

For packaging producers and brands, the key message is not that plastic pollution is imaginary. It is not. The stronger point is that claims about particles accumulating in specific organs must be supported by robust controls, repeatable methods and careful interpretation. In a field attracting intense public attention, overstated conclusions can undermine trust and make it harder for businesses, regulators and consumers to respond effectively.

The packaging debate needs evidence-led urgency: enough concern to reduce unnecessary plastic, but enough scientific discipline to avoid misleading conclusions.

One major issue is contamination. Plastic fibres and fragments can be present in laboratory air, clothing, syringes, pipettes, centrifuge tubes and other disposable labware. When researchers are searching for tiny numbers of particles in biological samples, even small background contamination can distort results. This is why blank samples, control tissues and cross-checking with multiple analytical techniques are essential.

The distinction between microplastics and nanoplastics is also important. Microplastics are generally larger and easier to identify, while nanoplastics are far smaller and may be more relevant to health because they can cross biological barriers and enter cells. Some laboratory studies suggest nanoplastics can damage cells or affect animal embryos, but translating those findings into real-world human exposure risk remains difficult.

Microplastics should not be dismissed either. They may trigger immune responses, contribute to inflammation or carry environmental chemicals into biological systems. However, current evidence does not yet prove that large amounts of plastic are building up in human organs, or that reported increases over time reflect real biological trends rather than limitations in measurement methods.

• Known issue: plastic pollution is widespread and packaging is one contributor to environmental exposure.
• Scientific challenge: detecting particles in human tissue is highly sensitive to contamination and method choice.
• Industry response: packaging reduction, recyclability and safer material design remain important priorities.

For the packaging industry, this debate reinforces the need for responsible innovation rather than defensive messaging. Companies should continue reducing unnecessary plastic, improving recyclability, supporting reusable systems and investing in materials that limit particle release. At the same time, sustainability claims should be grounded in verified data rather than fear-driven narratives.

Food and beverage packaging will remain central to public concern because it is one of the most visible routes through which consumers interact with plastic. Brands may face growing demand for paper-based formats, reusable containers, refill systems, glass, metal or bio-based alternatives. Yet substitutions must be assessed carefully, since every material carries its own impacts in production, transport, barrier performance and end-of-life management.

The emerging science also highlights the value of packaging designed for durability, clean recycling streams and reduced fragmentation. Poorly managed plastic waste can break down over time into smaller particles, so collection systems, reuse models and closed-loop recycling are part of the solution. Preventing leakage into the environment remains more practical than trying to remove tiny particles after they disperse.

Consumers may choose practical exposure-reduction steps, such as avoiding unnecessary contact between hot food and plastic containers, improving indoor ventilation or using water filtration where appropriate. But the broader solution must come from better packaging systems, stronger waste infrastructure and more reliable scientific standards.

The current debate should be seen as a sign of a maturing field, not a reason to ignore microplastics. As laboratories improve controls and develop standard operating procedures, the evidence will become clearer. Until then, packaging policy and innovation should be guided by caution, transparency and measurable environmental outcomes.

Image concept: a split scene showing plastic packaging waste under a microscope, laboratory sample testing with contamination controls, and sustainable packaging alternatives such as refillable containers, fibre-based packs and recyclable bottles.